Grant: Research Tools and Instruments - Category 1 (<$150,000)
Université Laval
$75,448.00
Analytical and purification system for the laboratory of medicinal chemistry
FY 2009-10
Summary
The cellular functions of a vast majority of proteins are performed through physical interactions with other proteins. These protein-protein interactions are essential for many cellular and biological processes. Therefore, the inhibition of these interactions with chemical compounds provides tremendous potential for the discovery of novel therapeutic agents and the development of innovative molecular tools to improve our understanding of biochemical pathways. As a result, the demand for molecules that are able to selectively disrupt specific protein-protein interactions is rapidly increasing.
The equipment requested herein, an analytical and purification high-performance liquid chromatography system (HPLC), will allow the development of novel approaches for the synthesis of engineerable peptidomimetic macrocyclic molecular scaffolds to target specific protein-protein interactions. The HPLC system will play a vital role in the laboratory of medicinal chemistry and will be used for purity analysis and purification of the synthesized molecules. Highly pure compounds are essential in structural studies, binding assays and for biological activity evaluation. As a result, the purification step is crucial for the development of selective protein-protein interaction inhibitors.
The development of protein-protein interaction inhibitors is a challenging and important goal in the context of fundamental research and pharmaceutical lead discovery. The development of these novel engineerable peptidomimetic macrocyclcic scaffolds will open new possibilities to inhibit intracellular proteins and will have an important impact in medicinal chemistry, chemical biology, and life sciences since protein-binding molecules are potential pharmacological agents, molecular tools to study biochemical pathways, and protein capture agents for the purification or detection of proteins in complex mixtures.
Program
Research Tools and Instruments - Category 1 (<$150,000)
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
390887-2010
Name nom
Biron, Eric
Department département
Pharmacie, Faculté de
Organization id
51
Institution établissement
Université Laval
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2009
Competition year année de concours
2010
Award amount
75448
Program id
EQPEQ
Program nane en
Research Tools and Instruments - Category 1 (<$150,000)
Program name fr
Outils et instruments de recherche - catégorie 1 (<150 000$)
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1504
Committee name en
Chemistry
Committee name fr
Chimie
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
3700
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Organic chemistry
Research subject fr
Chimie organique
Partie
1
Nb partie
1
Application title
Analytical and purification system for the laboratory of medicinal chemistry
Keyword
NA
Application summary
The cellular functions of a vast majority of proteins are performed through physical interactions with other proteins. These protein-protein interactions are essential for many cellular and biological processes. Therefore, the inhibition of these interactions with chemical compounds provides tremendous potential for the discovery of novel therapeutic agents and the development of innovative molecular tools to improve our understanding of biochemical pathways. As a result, the demand for molecules that are able to selectively disrupt specific protein-protein interactions is rapidly increasing.
The equipment requested herein, an analytical and purification high-performance liquid chromatography system (HPLC), will allow the development of novel approaches for the synthesis of engineerable peptidomimetic macrocyclic molecular scaffolds to target specific protein-protein interactions. The HPLC system will play a vital role in the laboratory of medicinal chemistry and will be used for purity analysis and purification of the synthesized molecules. Highly pure compounds are essential in structural studies, binding assays and for biological activity evaluation. As a result, the purification step is crucial for the development of selective protein-protein interaction inhibitors.
The development of protein-protein interaction inhibitors is a challenging and important goal in the context of fundamental research and pharmaceutical lead discovery. The development of these novel engineerable peptidomimetic macrocyclcic scaffolds will open new possibilities to inhibit intracellular proteins and will have an important impact in medicinal chemistry, chemical biology, and life sciences since protein-binding molecules are potential pharmacological agents, molecular tools to study biochemical pathways, and protein capture agents for the purification or detection of proteins in complex mixtures.